Literature DB >> 2452201

Characteristics and epitope mapping of a cloned human autoantigen La.

A D Sturgess1, M G Peterson, L J McNeilage, S Whittingham, R L Coppel.   

Abstract

The La (SS-B) polypeptide is a ribonucleoprotein against which high titer antinuclear antibodies (ANA) react in the human autoimmune disease primary Sjögren's syndrome. To identify the autoepitopes with which the ANA anti-La (anti-SS-B) reacts, we isolated a 1.4-kb cDNA clone for La from a lambda gt10 library made from a human Burkitt's cell line. This clone contained an open reading frame of 1065 bp, encoding a 40.1-kDa polypeptide that corresponded to the carboxyl-terminal end of the La protein. The predicted polypeptide sequence of the recombinant protein was highly charged and unrelated to any previously published sequence. We also compared this clone to a previously published cDNA sequence for La and demonstrated significant differences, particularly that the open reading frame in our cDNA continued for 926 additional bases 3' to a putative termination codon in the previously reported sequence. The recombinant La protein was expressed in Escherichia coli and tested for reactivity with 200 sera containing ANA of various specificities. Only the sera containing anti-La antibodies reacted with the cloned La. By expressing subclones of the La cDNA as fusion proteins with beta-galactosidase, we have localized at least one epitope for the binding of anti-La antibodies to the carboxyl-terminal 103 amino acids of the La protein. No anti-La binding could be demonstrated to the region of the La protein that had previously been predicted to contain an autoepitope for the binding of anti-La (SS-B) antibodies. Studies of cloned autoepitopes could provide important clues to the role ANA play in disease and lead to targeted intervention in the treatment of primary Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452201

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  B-cell epitopes of La and Ro autoantigens.

Authors:  S Whittingham
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 2.  Anti-Ro (SSA)/La (SSB) antibodies and Sjögren's syndrome.

Authors:  H M Moutsopoulos; L V Zerva
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 3.  Antinuclear antibody determination methods.

Authors:  D G Williams; P J Charles; M Field; S M Chua; R N Maini
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

4.  Analysis of autoantibodies to recombinant La (SS-B) peptides in systemic lupus erythematosus and primary Sjogren's syndrome.

Authors:  P Bini; J L Chu; C Okolo; K Elkon
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 5.  cDNA cloning of small nuclear and cytoplasmic RNA-associated proteins.

Authors:  A van Dam; I Winkel; R Smeenk; T Cuypers
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 6.  Structure and function of La and Ro RNPs.

Authors:  G J Pruijn; R L Slobbe; W J Van Venrooij
Journal:  Mol Biol Rep       Date:  1990       Impact factor: 2.316

Review 7.  Interactions between autoimmunity and molecular and cell biology. Bridges between clinical and basic sciences.

Authors:  E M Tan
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

8.  Ribonucleoprotein SS-B/La belongs to a protein family with consensus sequences for RNA-binding.

Authors:  E K Chan; K F Sullivan; E M Tan
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

9.  The nuclear autoantigen La/SS-associated antigen B: one gene, three functional mRNAs.

Authors:  D Grölz; M Bachmann
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

10.  Temporal correlation of antibody responses to different epitopes of the human La autoantigen.

Authors:  E W St Clair; J A Burch; M M Ward; J D Keene; D S Pisetsky
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.